BioNexus Gene Lab Statistics
Total Valuation
BGLC has a market cap or net worth of $4.49 million. The enterprise value is $601,636.
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BGLC has 17.97 million shares outstanding. The number of shares has increased by 18.10% in one year.
| Current Share Class | 17.97M |
| Shares Outstanding | 17.97M |
| Shares Change (YoY) | +18.10% |
| Shares Change (QoQ) | +1.70% |
| Owned by Insiders (%) | 30.98% |
| Owned by Institutions (%) | 0.99% |
| Float | 12.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.48 |
| Forward PS | n/a |
| PB Ratio | 0.48 |
| P/TBV Ratio | 0.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.98, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.98 |
| Quick Ratio | 3.99 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -21.11 |
Financial Efficiency
Return on equity (ROE) is -9.87% and return on invested capital (ROIC) is -2.65%.
| Return on Equity (ROE) | -9.87% |
| Return on Assets (ROA) | -2.29% |
| Return on Invested Capital (ROIC) | -2.65% |
| Return on Capital Employed (ROCE) | -4.30% |
| Revenue Per Employee | $308,662 |
| Profits Per Employee | -$31,385 |
| Employee Count | 30 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 6.42 |
Taxes
In the past 12 months, BGLC has paid $22,315 in taxes.
| Income Tax | 22,315 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.27% in the last 52 weeks. The beta is 1.69, so BGLC's price volatility has been higher than the market average.
| Beta (5Y) | 1.69 |
| 52-Week Price Change | -64.27% |
| 50-Day Moving Average | 0.35 |
| 200-Day Moving Average | 0.38 |
| Relative Strength Index (RSI) | 30.98 |
| Average Volume (20 Days) | 1,470,315 |
Short Selling Information
The latest short interest is 233,621, so 1.30% of the outstanding shares have been sold short.
| Short Interest | 233,621 |
| Short Previous Month | 366,105 |
| Short % of Shares Out | 1.30% |
| Short % of Float | 1.88% |
| Short Ratio (days to cover) | 1.16 |
Income Statement
In the last 12 months, BGLC had revenue of $9.26 million and -$941,560 in losses. Loss per share was -$0.05.
| Revenue | 9.26M |
| Gross Profit | 1.25M |
| Operating Income | -412,013 |
| Pretax Income | -2.64M |
| Net Income | -941,560 |
| EBITDA | -317,296 |
| EBIT | -412,013 |
| Loss Per Share | -$0.05 |
Full Income StatementBalance Sheet
The company has $4.14 million in cash and $245,142 in debt, giving a net cash position of $3.89 million or $0.22 per share.
| Cash & Cash Equivalents | 4.14M |
| Total Debt | 245,142 |
| Net Cash | 3.89M |
| Net Cash Per Share | $0.22 |
| Equity (Book Value) | 9.39M |
| Book Value Per Share | 0.52 |
| Working Capital | 5.62M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$2.43 million and capital expenditures -$223,904, giving a free cash flow of -$2.65 million.
| Operating Cash Flow | -2.43M |
| Capital Expenditures | -223,904 |
| Free Cash Flow | -2.65M |
| FCF Per Share | -$0.15 |
Full Cash Flow StatementMargins
Gross margin is 13.47%, with operating and profit margins of -4.45% and -10.17%.
| Gross Margin | 13.47% |
| Operating Margin | -4.45% |
| Pretax Margin | -9.93% |
| Profit Margin | -10.17% |
| EBITDA Margin | -3.43% |
| EBIT Margin | -4.45% |
| FCF Margin | n/a |